Amino acid residues required for binding of lymphocyte function-associated antigen 3 (CD58) to its counter-receptor CD2.
Open Access
- 1 January 1995
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 181 (1) , 429-434
- https://doi.org/10.1084/jem.181.1.429
Abstract
Efficient activation and regulation of the cellular immune response requires engagement of T cell accessory molecules as well as the antigen-specific T cell receptor. The lymphocyte function-associated antigen (LFA) 3 (CD58)/CD2 accessory pathway, one of the first discovered, has been extensively characterized in terms of structure and function of the CD2 molecule, which is present on all T lymphocytes and natural killer cells of the human immune system. The binding site of human CD2 for LFA-3 has been localized to two epitopes on one face of the first immunoglobulin (Ig)-like domain of this two-domain, Ig superfamily molecule. Human LFA-3 is genetically linked and is 21% identical in amino acid sequence to CD2, suggesting that this adhesive pair may have evolved from a single ancestral molecule. We have aligned the amino acid sequences of LFA-3 and CD2 and mutagenized selected amino acids in the first domain of LFA-3 that are analogous to those implicated in the binding site of CD2. The data show that K30 and K34, in the predicted C-C' loop, and D84, in the predicted F-G loop of LFA-3, are involved in binding to CD2, suggesting that two complementary sites on one face of the first domain of each molecule bind to each other.Keywords
This publication has 24 references indexed in Scilit:
- Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5å resolutionStructure, 1994
- Proton resonance assignments and secondary structure of the 13.6 kDa glycosylated adhesion domain of human CD2Biochemistry, 1993
- Mutational analysis of the CD2/CD58 interaction: the binding site for CD58 lies on one face of the first domain of human CD2.The Journal of Experimental Medicine, 1993
- The NH2‐terminal domain of rat CD2 binds rat CD48 with a low affinity and binding does not require glycosylation of CD2European Journal of Immunology, 1993
- Crystal structure at 2.8 Å resolution of a soluble form of the cell adhesion molecule CD2Nature, 1992
- CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation.The Journal of Experimental Medicine, 1992
- Overlapping but Nonidentical Binding Sites on CD2 for CD58 and a Second Ligand CD59Science, 1992
- A birth certificate for CD2Nature, 1991
- Structural and binding analysis of a two domain extracellular CD2 molecule.The Journal of Experimental Medicine, 1989
- Blast-1 possesses a glycosyl-phosphatidylinositol (GPI) membrane anchor, is related to LFA-3 and OX-45, and maps to chromosome 1q21-23.The Journal of Experimental Medicine, 1989